Aiolos Bio Launches With $245M As Asthma-Focused Funding Accelerates

San Francisco- and London-based Aiolos Bio, a newly launched startup with an asthma drug in clinical trials, announced that it raised $245 million in Series A funding.

Related Keywords

United States ,China ,America ,Aiolos Bio ,Dom Guzman ,Knopp Biosciences ,Bain Capital Life Sciences ,Jiangsu Hengrui Pharmaceuticals ,Atlas Venture ,Allergy Foundation Of America ,London Based Aiolos Bio ,Forbion Capital Partners ,Sofinnova Investments ,Jiangsu Hengrui ,Massachusetts Based Upstream Bio ,Areteia Therapeutics ,Bain Capital Life ,Maverick Capital ,Pennsylvania Based Knopp Biosciences ,Allergy Foundation ,Crunchbase Pro ,